article thumbnail

EU probes low platelet safety issue with COVID-19 shots

pharmaphorum

EU regulators are reviewing reports of low blood platelets in patients who received any of the three approved COVID-19 vaccines from Pfizer/BioNTech, AstraZeneca and Moderna. The PRAC will investigate and if a causal relationship is confirmed or considered likely, an update to the products’ labels will be the most likely outcome.

article thumbnail

Novartis signs new initial agreement with BioNTech to support fill and finish of the mRNA Pfizer-BioNTech COVID-19 vaccine

The Pharma Data

Novartis blazoned moment that it has inked an original agreement to work its manufacturing capacity and capabilities to address the COVID-19 epidemic by expanding its support of the filler and finish of the Pfizer-BioNTech COVID-19 vaccine. This new agreement follows a first contract inked before this time.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

PRAC investigates heart inflammation reports with Pfizer vaccine

The Pharma Data

During an early May meeting, the European Medicines Agency’s safety committee concluded two reviews of safety signals related to COVID-19 vaccines, while it continued following other vaccine-related “topics of interest.” Separately, EMA’s human medicines committee has begun a rolling review of another monoclonal antibody to treat COVID-19.

article thumbnail

CarboFix

The Pharma Data

It’s been tested in hundreds of different studies… And it has a long history of being used in traditional Chinese medicine…. Their waists got smaller… They also saw an improvement in fat-regulating hormones. …so you can see that there are no fillers…. But the benefits go much deeper than that.